1
Cyril C Curtain, Harvey Snook: Method for harvesting algae. Commonwealth Scientific and Industrial Research Organization, Betatene, Sughrue Mion Zinn Macpeak and Seas, November 19, 1985: US04554390 (41 worldwide citation)

A method for harvesting algae of the genus Dunaliella from suspensions thereof in brines containing sodium chloride at a concentration of about 3M or above, wherein the algal suspension is contacted with an adsorbent having a hydrophobic surface so as to adsorb the algae thereon, and the adsorbent w ...


2

3
Lance Elliott Schlipalius: Aqueous formulations of water-insoluble therapeutic agent comprising carotenoids and/or tocopherols. Betatene, Burns Doane Swecker & Mathis, June 30, 1998: US05773026 (22 worldwide citation)

The invention is a carotenoid agent for inhibiting the conversion of epithelial cells to tumours, the agent including an effective amount of a water insoluble carotenoid component in a suitable non-toxic carrier medium.


4
Lance E Schlipalius: High cis beta-carotene composition. Betatene of Cheltenham, Burns Doane Swecker & Mathis, March 18, 1997: US05612485 (17 worldwide citation)

A carotenoid composition derived from a natural source wherein at least 50% by weight of the carotenoid content of the composition is cis beta-carotene and preferably 9 cis beta-carotene. Typically, the beta-carotene content of the composition is predominantly 9 cis beta-carotene.


5
Lance Elliott Schlipalius: Therapeutic agent for the treatment of melanomas. Betatene, Burns Doane Swecker & Mathis L, January 6, 1998: US05705180 (15 worldwide citation)

The present invention provides a therapeutic agent for the treatment of a melanoma or melanomas by injection or intravenously including a mixture of: (a) a water soluble dispersible component; (b) an emulsifier component; and (c) a water insoluble carotenoid component in a suitable carrier medium.


6
Schlipalius Lance Elliot: Therapeutic agent for the treatment of melanomas. Betatene, January 3, 1996: EP0689426-A1

PCT No. PCT/AU94/00141 Sec. 371 Date Sep. 22, 1995 Sec. 102(e) Date Sep. 22, 1995 PCT Filed Mar. 22, 1994 PCT Pub. No. WO94/21231 PCT Pub. Date Sep. 29, 1994The present invention provides a therapeutic agent for the treatment of a melanoma or melanomas by injection or intravenously including a mixtu ...


7
Schlipalius Lance Elliott: Water dispersible therapeutic compounds. Betatene, January 3, 1996: EP0689427-A1

PCT No. PCT/AU94/00143 Sec. 371 Date Sep. 22, 1995 Sec. 102(e) Date Sep. 22, 1995 PCT Filed Mar. 22, 1994 PCT Pub. No. WO94/21232 PCT Pub. Date Sep. 29, 1995The invention is a carotenoid agent for inhibiting the conversion of epithelial cells to tumours, the agent including an effective amount of a ...


8
Schlipalius Lance Elliott: Carotenoid composition.. Betatene, June 22, 1994: EP0602137-A1

The invention comprises a carotenoid composition comprising: a) a carotenoid in an oil solvent wherein the weight of carotenoid in the carotenoid composition is up to 12 %; b) a dispersion of a water dispersible matrix and a stabilizer, and optionally a non-oil solvent; and c) an emulsifier, wherein ...


9
Schlipalius Lance Elliott: High cis beta-carotene composition.. Betatene, March 22, 1995: EP0643692-A1

A carotenoid composition derived from a natural source wherein at least 50 % by weight of the carotenoid content of the composition is cis beta-carotene and preferably 9 cis beta-carotene. Typically, the beta-carotene content of the composition is predominantly 9 cis beta-carotene.


10
Schlipalius Lance Elliott: Carotenoid composition. Betatene, Schlipalius Lance Elliott, McMASTER Wayne, March 18, 1993: WO/1993/004598

The invention comprises a carotenoid composition comprising: a) a carotenoid in an oil solvent wherein the weight of carotenoid in the carotenoid composition is up to 12 %; b) a dispersion of a water dispersible matrix and a stabilizer, and optionally a non-oil solvent; and c) an emulsifier, wherein ...



Click the thumbnails below to visualize the patent trend.